(lp0
S'MediciNova Inc. MNOV  Wall Street Journal - Feb 11, 2011 News MediciNova Inc.MNOV. Significant News Only. 01/23/17; Press Release. MediciNova Announces Publication of Positive Findings on MN-166  in Alcohol Dependence.'
p1
aS'MediciNova Inc.  Moves Lower on Volume Spike for February 21 Equities.com - Feb 21, 2017 MediciNova Inc.  traded on unusually high volume on Feb. 21, as the stock lost 1.15% to close at $6.04. On the day, MediciNova Inc. saw 62,028 shares trade hands on 375 trades. Considering that the stock averages only a daily volume of 39,291&nbsp;...'
p2
aS'MediciNova Announces Positive Findings from Completed Trial of MN-166 ... GlobeNewswire  - Feb 6, 2017 LA JOLLA, Calif., Feb. 06, 2017  -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market  and the JASDAQ Market of the Tokyo Stock Exchange , today announced&nbsp;...'
p3
aS'MediciNova Inc.  Soars 5.74% on February 27 Equities.com - Feb 27, 2017 MediciNova Inc.  had a good day on the market for Monday February 27 as shares jumped 5.74% to close at $6.45. About 58,763 shares traded hands on 511 trades for the day, compared with an average daily volume of 72,676 shares out of a total&nbsp;...'
p4
aS"Option Market: MediciNova Inc Risk Hits An Extraordinary High CML News - Feb 13, 2017 We're going to look at a proprietary risk rating for the next 30-days built by Capital Market Laboratories  based on a large number of interactions of data points, many of which come directly from the option market for MediciNova Inc (NASDAQ ..."
p5
aS'MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN ... GlobeNewswire  - Jul 24, 2016 LA JOLLA, Calif., July 24, 2016  -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market  and the JASDAQ Market of the Tokyo Stock Exchange , today announced&nbsp;...'
p6
aS'MediciNova Inc Stock Volatility Hits A Tumbling Low CML News - Mar 5, 2017 This is a proprietary realized volatility rating created by Capital Market Laboratories  based on a large number of data interactions for MediciNova Inc  . We examine the little used gem of daily stock volatility over a 20-day and ...'
p7
aS'MediciNova Announces MN-166  Glioblastoma Abstract Selected for ... GlobeNewswire  - Feb 27, 2017 LA JOLLA, Calif., Feb. 27, 2017  -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market  and the JASDAQ Market of the Tokyo Stock Exchange , today announced&nbsp;...'
p8
aS"MediciNova's Ibudilast And The Phase IIb Trial Offer Steady Outlook Seeking Alpha - Jan 18, 2016 Recent news surrounding Medicinova's  progress has concerned its drug MN-166, or ibudilast, and its treatment of ALS, commonly known as Lou Gehrig's disease."
p9
aS'MediciNova, Inc.  Pressured Under Trend Lines Midway Monitor - 8 hours ago MediciNova, Inc.  shares have been on a recent steady downtrend, causing some worry for shareholders. It is important to consider the moving averages of a downtrending security.'
p10
a.